INSIGHTS ON PHARMACEUTICAL INSPECTION

• Understanding Injectable Drug Container Closure Systems

  Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

• HVLD Technology Pre-Filled Syringe Inspection

  Advanced HVLD technology delivers non-invasive, deterministic inspection for pre-filled syringes. Learn how this method improves reliability and patient safety compared to traditional approaches.

• Enhance Accuracy And Efficiency In Lightweight Applications

  Streamline your operations within a single framework with advanced checkweighers that enhance industrial quality control with precise weight measurements and regulatory compliance.

• Visual Inspection Of Advanced Therapy Medicinal Products

  Discover how expert database systems for inspection defect management and control help cell and gene therapies meet the requirements of USP-790 to assure they are essentially free from particulate matter.

• What Pharma And Biopharma Should Know About Container Closure Integrity

  8/1/2024

  Explore high voltage leak detection, headspace analysis, and vacuum and pressure decay as applied in pharmaceutical manufacturing.

• Why Is It Important To Have Properly Trained Visual Inspectors?

  8/4/2025

  Properly trained visual inspectors are crucial for identifying defects in parenteral drugs, safeguarding patient safety and product quality.

• Microbial Challenge In-Use Studies

  6/13/2024

  Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.

• What Is The Position Of Regulatory Authorities On PUPSIT?

  5/2/2025

  PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.

• Lessons From FDA 483s And Warning Letters: Cleanroom Compliance

  12/8/2025

  Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.